Bellco Capital

Bellco Capital is a direct investment firm established in 2003 by renowned oncology entrepreneurs Rebecka Belldegrun, M.D., and Arie Belldegrun, M.D. Based in Los Angeles, California, the firm operates as a Single Family Office, managing wealth primarily from the successful sale of Kite Pharma and other biopharmaceutical ventures. Bellco Capital focuses on private equity and venture investments, targeting companies with ambitious goals for growth and transformation. The firm specializes in life sciences but also invests in real estate, consumer products, and media. With a portfolio of over 12 companies, Bellco Capital typically engages in Series A and Series B funding rounds, while also providing strategic advisory services to its portfolio companies. This includes operational guidance, mentorship, and access to industry networks, aimed at fostering long-term relationships and supporting the growth of innovative businesses.

Targets high-growth companies primarily in life sciences, offering capital plus strategic advisory, mentorship, and industry access.